Israel arrests 27 more Palestinians in West Bank raids

Israel arrests 27 more Palestinians in West Bank raids

Israeli military raids in the occupied West Bank led to the detention of at least 27 Palestinians, including a journalist, in various cities and towns. Witnesses reported that homes were searched and vandalized during the raids, with clashes erupting in some areas. The escalating tensions come amid ongoing Israeli attacks on Gaza, resulting in many…

Read More
Only BJP can restore statehood to J&K: PM Modi

Only BJP can restore statehood to J&K: PM Modi

Prime Minister Narendra Modi addressed a BJP rally in Srinagar, emphasizing that only the BJP can restore statehood to Jammu and Kashmir. He praised the high voter turnout in recent elections and criticized the Congress, NC, and PDP parties for their failures in the past. Modi highlighted the improvements made in education and employment opportunities…

Read More
CIA officer who drugged, photographed and sexually assaulted dozens of women gets 30 years in prison as victims stare him down

CIA officer who drugged, photographed and sexually assaulted dozens of women gets 30 years in prison as victims stare him down

A former CIA officer, Brian Jeffrey Raymond, was sentenced to 30 years in federal prison for drugging, photographing, and sexually assaulting over two dozen women in different postings around the world. Victims described feeling deceived by a man who appeared trustworthy and part of an agency meant to protect the world. Raymond’s assaults date back…

Read More
Thursday’s analyst calls: Medical device stock a buy, JPMorgan says sell this discount retailer

Thursday’s analyst calls: Medical device stock a buy, JPMorgan says sell this discount retailer

Analysts are talking about stocks like DoorDash, NextEra Energy Partners, Hertz, and Five Below. BTIG suggests buying DoorDash, while Jefferies recommends NextEra despite concerns. Barclays initiated Hertz at underweight, and JPMorgan downgraded Five Below to sell. On the other hand, Piper Sandler believes Abbott Laboratories is a buy. These calls reflect the analysts’ insights on…

Read More